Clinical Trials

Epilepsy Phenome/Genome Project (EPGP)

Location:

Jacksonville,  FL,  Scottsdale and Phoenix,  AZ,  Rochester,  MN

Trial status:

Inactive

Why is this study being done?

The purpose of this study is to look for genes that are the cause of epilepsy and to look for genes that have an impact on the effectiveness of over the counter and prescription medicines used to treat epilepsy.

Who is eligible to participate?

Participants must have epilepsy and have a sibling with epilepsy, OR, have specific epilepsy dx of: infantile spasms, lennox gastaut syndrome, periventricular nodular heterotopia, OR polymicrogyria and have both parents available to participate in the blood draw and questionnaire.

What is involved?

Participants will have 2 vials of blood drawn and will be asked to complete a set of detailed questionnaires (demographics, medical history information, etc.)

How long is the study?

Participation will require a one time visit, which will last approximately 2-3 hours. Then, approximately one year after participation, phone contact will be made to complete a follow-up questionnaire that will last approximately 1/2 hour.

Last updated: 12/19/2012

NCT ID: